Volume 15 - Issue 7 - July 2002

Feature »

A Comprehensive Review Of Topical Agents

By Jonathan Moore, DPM, MS, A. Patti Smith, MD, and John S. Steinberg, DPM | 11096 reads | 0 comments

The wound is in constant evolution. Changes arise and you need to be able to respond accordingly in your treatment course. Indeed, understanding the biochemical dynamics of wound healing is vital for proper product selection (see “Understanding The Phases Of Wound Healing” on page 42). The challenge to the practitioner is to have the knowledge base with which to sort through the thousands of topical agents and dressings available today.

Insights On Topical Agents With Collagen
Let’s start out with a discussion of the biologic topical agents that contain collagen. Collagen hastens wou



Feature »

How To Use VAC Therapy On Chronic Wounds

By Brian Short, DPM, Matthew Claxton, DPM, and David G. Armstrong, DPM | 30739 reads | 1 comments

Chronic wounds such as diabetic foot ulcers, venous stasis ulcers and decubitis ulcers are leading causes of morbidity and mortality in elderly patients and significantly contribute to health care costs.1-4 Wounds of these types often lead to complications such as infection and amputation.5-7 The ADA currently reports diabetes is prevalent in at least 17 million Americans, many of whom do not know they have the disease. Of these, approximately 15 percent will experience a foot ulcer or other complication requiring hospitalization during the course of the disease.8, 9
Similarly, venous wounds



Editor's Perspective »

Understanding The Changing Face Of Diabetes

By Jeff Hall, Editor-In-Chief | 1556 reads | 0 comments

New figures from the Centers For Disease Control (CDC) continue to cast a sobering view on treating diabetes in the years to come. Now there are 17 million Americans who have the disease and nearly six million of them are unaware they have the condition, according to CDC estimates. The prevalence of the disease, the sixth-leading cause of death in the United States, has increased 33 percent in the last decade. Even more troubling is the fact that the demographics of the diabetes population are growing wider.
The CDC notes that over a million new cases will be diagnosed each year among patien



Letters »

Defining The APMA's Position On HIPAA

1887 reads | 0 comments

I read with great interest your recent editorial regarding HIPAA (see “Ready Or Not, Here Comes HIPAA,” page 14, April issue). As Vice-President of the APMA and Chair of the Health Policy Committee, I have direct oversight of these activities. We fully agree with the need for education regarding HIPAA and implementation of the final guidelines.
The APMA is producing a HIPAA Compliance Manual that will be free to APMA members. However, after the March release of revisions to the proposed rule and final standards, we decided to delay production of the manual until 60 days after the final r



Technology In Practice »

C-Beam Technology May Open New Horizons For DPMs

By Brian McCurdy, Associate Editor | 2377 reads | 0 comments

Podiatrists looking for new ways of treating plantar verruca may want to check out a new advance in laser treatments. The C-beam is a laser that penetrates below the epidermal surface to get to the root of plantar and palmar psoriasis. Frank Russo, DPM, has been using the C-beam for several weeks to treat plantar warts and other ailments and says it’s the “newest and best thing going.”
“(The C-Beam) is easy to use for us and the patients have been really receptive to it," says Dr. Russo. "If I had a plantar wart, this is how I would treat it.”
Dr. Russo says the C-beam is differe